Additional file 1 of Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study

Abstract

Additional file 1: Supplementary file 1. A list of participating centers of BBCAPX trial